Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CS
1651
DELISTED
Credit Suisse Group
CS
| $9.71M | 0.01% |
544,040
-28,163
| -5% | -$466K |
|
1652
CALL
Advance Auto Parts
AAP
$3.41B
| $9.71M | 0.01% |
97,400
-34,000
| -26% | -$3.13M |
|
1653
PUT
Canadian Natural Resources
CNQ
$98.9B
| $9.71M | 0.01% |
554,811
+170,915
| +45% | +$2.87M |
|
|
DERM
1654
DELISTED
Dermira, Inc.
DERM
| $9.69M | 0.01% |
348,491
-145,307
| -29% | -$3.85M |
|
1655
CALL
NetApp
NTAP
$40.6B
| $9.68M | 0.01% |
174,900
+46,300
| +36% | +$2.32M |
|
1656
PUT
Riot Platforms
RIOT
$7.14B
| $9.67M | 0.01% |
+340,500
| New | +$4.78M |
|
1657
CALL
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$24.7B
| $9.67M | 0.01% |
1,051,500
+460,500
| +78% | +$4.37M |
|
|
NAV
1658
PUT
DELISTED
Navistar International
NAV
| $9.65M | 0.01% |
225,000
+41,800
| +23% | +$1.74M |
|
1659
CALL
Edwards Lifesciences
EW
$52.8B
| $9.64M | 0.01% |
256,500
+10,500
| +4% | +$385K |
|
1660
Adeia
ADEA
$3.29B
| $9.63M | 0.01% |
1,492,688
-602,664
| -29% | -$3.54M |
|
1661
CALL
LyondellBasell Industries
LYB
$20.6B
| $9.62M | 0.01% |
87,200
-78,500
| -47% | -$8.14M |
|
1662
PUT
Ambarella
AMBA
$3.6B
| $9.62M | 0.01% |
163,700
+27,200
| +20% | +$1.51M |
|
|
CLR
1663
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $9.61M | 0.01% |
181,500
+63,700
| +54% | +$2.79M |
|
|
NATI
1664
DELISTED
National Instruments Corp
NATI
| $9.61M | 0.01% |
230,884
+170,688
| +284% | +$7.46M |
|
1665
iShares MSCI EAFE Value ETF
EFV
$30.1B
| $9.61M | 0.01% |
+174,063
| New | +$9.56M |
|
1666
PUT
C.H. Robinson
CHRW
$17.4B
| $9.6M | 0.01% |
107,700
+56,900
| +112% | +$4.64M |
|
1667
Zimmer Biomet
ZBH
$19.2B
| $9.59M | 0.01% |
81,864
-247,415
| -75% | -$28M |
|
1668
PUT
Nutanix
NTNX
$18B
| $9.59M | 0.01% |
271,800
-8,100
| -3% | -$245K |
|
|
FIT
1669
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $9.58M | 0.01% |
1,678,000
+1,014,000
| +153% | +$6.45M |
|
|
HZNP
1670
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.55M | 0.01% |
654,433
-993,024
| -60% | -$13.9M |
|
|
AEL
1671
DELISTED
American Equity Investment Life Holding Company
AEL
| $9.54M | 0.01% |
310,541
+299,590
| +2,736% | +$9.09M |
|
|
MTGE
1672
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $9.54M | 0.01% |
515,652
+349,908
| +211% | +$6.56M |
|
1673
Carpenter Technology
CRS
$27.1B
| $9.52M | 0.01% |
186,673
-35,463
| -16% | -$1.76M |
|
1674
Qorvo
QRVO
$8.66B
| $9.49M | 0.01% |
142,539
+138,302
| +3,264% | +$10.1M |
|
1675
CALL
Tapestry
TPR
$26.1B
| $9.49M | 0.01% |
214,600
+50,700
| +31% | +$2.09M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.